2023 Q3 Form 10-K Financial Statement

#000119312523234137 Filed on September 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $9.291M $32.07M
YoY Change 31.27% 29.36%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $177.0K $176.0K $663.0K
YoY Change 6.63% 3.53% -1.78%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $4.708M $10.08M
YoY Change 468.6% 298.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $641.0K $769.0K $6.260M
YoY Change -76.34% -44.44% -20.02%
Income Tax $175.0K $172.0K $1.600M
% Of Pretax Income 27.3% 22.37% 25.56%
Net Earnings $466.0K $597.0K $4.660M
YoY Change -76.33% -42.32% -19.43%
Net Earnings / Revenue 5.02% 14.53%
Basic Earnings Per Share $0.15 $1.50
Diluted Earnings Per Share $0.14 $0.20 $1.46
COMMON SHARES
Basic Shares Outstanding 3.355M 3.355M 3.113M
Diluted Shares Outstanding 3.267M 3.195M

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.12M $36.56M
YoY Change -10.48% -66.31%
Cash & Equivalents $13.58M $10.99M
Short-Term Investments $24.53M $25.57M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.01M $11.09M $11.09M
YoY Change 17.52% 16.7% 16.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.00M $11.04M $11.04M
YoY Change 12.79% 20.41% 20.41%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $870.7M $849.0M $849.0M
YoY Change 7.91% -1.0% -1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.500M $2.899M $2.899M
YoY Change 253.89% 326.95% 326.95%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $16.00M $10.79M $10.79M
YoY Change 64.61% 16.69% 16.69%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.50M $13.69M $13.69M
YoY Change 1871.69% 1915.61% 1915.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.900M $8.723M $8.723M
YoY Change -16.62% -2.61% -2.61%
Total Long-Term Liabilities $6.900M $8.723M $8.723M
YoY Change -16.62% -2.61% -2.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.50M $13.69M $13.69M
Total Long-Term Liabilities $6.900M $8.723M $8.723M
Total Liabilities $804.1M $777.2M $777.2M
YoY Change 8.75% -1.1% -1.1%
SHAREHOLDERS EQUITY
Retained Earnings $43.16M $43.37M
YoY Change 4.56% 7.44%
Common Stock $51.69M $51.58M
YoY Change 1.51% 2.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.59M $71.75M $71.75M
YoY Change
Total Liabilities & Shareholders Equity $870.7M $849.0M $849.0M
YoY Change 7.91% -1.0% -1.0%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income $466.0K $597.0K $4.660M
YoY Change -76.33% -42.32% -19.43%
Depreciation, Depletion And Amortization $177.0K $176.0K $663.0K
YoY Change 6.63% 3.53% -1.78%
Cash From Operating Activities $1.001M $1.114M $2.766M
YoY Change -451.23% -62.44% -68.09%
INVESTING ACTIVITIES
Capital Expenditures $93.00K $108.0K $2.250M
YoY Change 232.14% -202.86% 481.4%
Acquisitions
YoY Change
Other Investing Activities -$25.95M -$5.497M -$54.87M
YoY Change 38.76% -83.01% -19.8%
Cash From Investing Activities -$26.04M -$5.605M -$57.12M
YoY Change 39.03% -82.73% -16.98%
FINANCING ACTIVITIES
Cash Dividend Paid $1.269M
YoY Change 18.93%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 27.63M 6.014M -10.47M
YoY Change -160.85% -92.25% -114.3%
NET CHANGE
Cash From Operating Activities 1.001M 1.114M 2.766M
Cash From Investing Activities -26.04M -5.605M -57.12M
Cash From Financing Activities 27.63M 6.014M -10.47M
Net Change In Cash 2.594M 1.523M -64.82M
YoY Change -104.03% -96.84% -595.74%
FREE CASH FLOW
Cash From Operating Activities $1.001M $1.114M $2.766M
Capital Expenditures $93.00K $108.0K $2.250M
Free Cash Flow $908.0K $1.006M $516.0K
YoY Change -390.1% -67.24% -93.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001514743
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-35226
CY2023 dei Entity Registrant Name
EntityRegistrantName
IF BANCORP, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-1834449
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
201 East Cherry Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Watseka
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60970
CY2023 dei City Area Code
CityAreaCode
815
CY2023 dei Local Phone Number
LocalPhoneNumber
432-2476
CY2023 dei Security12b Title
Security12bTitle
Common Stock
CY2023 dei Trading Symbol
TradingSymbol
IROQ
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
41801000
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3354626
CY2023 dei Auditor Firm
AuditorFirmId
686
CY2023 dei Auditor Name
AuditorName
FORVIS, LLP
CY2023 dei Auditor Location
AuditorLocation
Decatur, Illinois
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
10717000
CY2022Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
74494000
CY2023Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
271000
CY2022Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1317000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10988000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75811000
CY2023Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1250000
CY2022Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1500000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201299000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
220906000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7052000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
587457000
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
518931000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9212000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8704000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11092000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9505000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3127000
CY2022Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3142000
CY2023Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
31000
CY2022Q2 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
120000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
2781000
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
2023000
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
14761000
CY2022Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
14373000
CY2023Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1482000
CY2022Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1463000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11037000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9166000
CY2023Q2 us-gaap Other Assets
OtherAssets
3671000
CY2022Q2 us-gaap Other Assets
OtherAssets
618000
CY2023Q2 us-gaap Assets
Assets
848976000
CY2022Q2 us-gaap Assets
Assets
857558000
CY2023Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
107567000
CY2022Q2 us-gaap Demand Deposit Accounts
DemandDepositAccounts
104944000
CY2023Q2 iroq Deposits Savings Negotiable Order Of Withdrawal Now And Money Market Deposits
DepositsSavingsNegotiableOrderOfWithdrawalNowAndMoneyMarketDeposits
344151000
CY2022Q2 iroq Deposits Savings Negotiable Order Of Withdrawal Now And Money Market Deposits
DepositsSavingsNegotiableOrderOfWithdrawalNowAndMoneyMarketDeposits
396600000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
264058000
CY2022Q2 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
246909000
CY2023Q2 iroq Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
19538000
CY2022Q2 iroq Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
3567000
CY2023Q2 us-gaap Deposits
Deposits
735314000
CY2022Q2 us-gaap Deposits
Deposits
752020000
CY2023Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
10787000
CY2022Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
9244000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
19500000
CY2022Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
15000000
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1233000
CY2022Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
503000
CY2023Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
2431000
CY2022Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
2620000
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1666000
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
176000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
216000
CY2022Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
0
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
6076000
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
6337000
CY2023Q2 us-gaap Liabilities
Liabilities
777223000
CY2022Q2 us-gaap Liabilities
Liabilities
785900000
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3354626
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3354626
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3257626
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3257626
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
33000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
32000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
51543000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
50342000
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
153960
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
173205
CY2023Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
1540000
CY2022Q2 us-gaap Unearned Esop Shares
UnearnedESOPShares
1732000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43365000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40362000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21648000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17346000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71753000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
71658000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
848976000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
857558000
CY2023 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26106000
CY2022 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
20195000
CY2023 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
5359000
CY2022 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
4296000
CY2023 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
106000
CY2022 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
51000
CY2023 iroq Federal Home Loan Bank Dividends
FederalHomeLoanBankDividends
198000
CY2022 iroq Federal Home Loan Bank Dividends
FederalHomeLoanBankDividends
120000
CY2023 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
303000
CY2022 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
130000
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
32072000
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
24792000
CY2023 us-gaap Interest Expense Deposits
InterestExpenseDeposits
7997000
CY2022 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2068000
CY2023 iroq Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvances
2062000
CY2022 iroq Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvances
382000
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
16000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
79000
CY2023 us-gaap Interest Expense
InterestExpense
10075000
CY2022 us-gaap Interest Expense
InterestExpense
2529000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
21997000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
22263000
CY2023 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-228000
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
492000
CY2023 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
22225000
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
21771000
CY2023 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
651000
CY2022 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
692000
CY2023 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
773000
CY2022 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
1131000
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
-171000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
-275000
CY2023 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
360000
CY2022 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
797000
CY2023 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
172000
CY2022 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
515000
CY2023 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
388000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
488000
CY2023 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
1268000
CY2022 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
1495000
CY2023 us-gaap Noninterest Income
NoninterestIncome
4069000
CY2022 us-gaap Noninterest Income
NoninterestIncome
5504000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12712000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13051000
CY2023 us-gaap Occupancy Net
OccupancyNet
1006000
CY2022 us-gaap Occupancy Net
OccupancyNet
951000
CY2023 us-gaap Equipment Expense
EquipmentExpense
2499000
CY2022 us-gaap Equipment Expense
EquipmentExpense
1994000
CY2023 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
333000
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
197000
CY2023 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
99000
CY2022 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
71000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
538000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
404000
CY2023 us-gaap Professional Fees
ProfessionalFees
459000
CY2022 us-gaap Professional Fees
ProfessionalFees
398000
CY2023 iroq Supervisory Examinations
SupervisoryExaminations
173000
CY2022 iroq Supervisory Examinations
SupervisoryExaminations
162000
CY2023 iroq Audit And Accounting Services
AuditAndAccountingServices
182000
CY2022 iroq Audit And Accounting Services
AuditAndAccountingServices
142000
CY2023 iroq Organizational Dues And Subscriptions
OrganizationalDuesAndSubscriptions
56000
CY2022 iroq Organizational Dues And Subscriptions
OrganizationalDuesAndSubscriptions
52000
CY2023 iroq Insurance Bond Premiums
InsuranceBondPremiums
206000
CY2022 iroq Insurance Bond Premiums
InsuranceBondPremiums
187000
CY2023 iroq Telephone And Postage
TelephoneAndPostage
163000
CY2022 iroq Telephone And Postage
TelephoneAndPostage
160000
CY2023 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
28000
CY2022 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-6000
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1636000
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1673000
CY2023 us-gaap Noninterest Expense
NoninterestExpense
20034000
CY2022 us-gaap Noninterest Expense
NoninterestExpense
19448000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6260000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7827000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2043000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4660000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
5784000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.5
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.88
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.84
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4660000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
5784000
CY2023 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-1824000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-7902000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4574000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-19821000
CY2023 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-49000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-78000
CY2023 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-122000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-197000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4452000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-19624000
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
60000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
137000
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
150000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
345000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4302000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-19279000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
358000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13495000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
85304000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
5784000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-19279000
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2022 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1067000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
315000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
156000
CY2022 iroq Esop Shares Earned Shares
ESOPSharesEarnedShares
19245
CY2022 iroq Esop Shares Earned
EsopSharesEarned
445000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
71658000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4660000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4302000
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4
CY2023 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1269000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
732000
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
327000
CY2023 iroq Esop Shares Earned Shares
ESOPSharesEarnedShares
19245
CY2023 iroq Esop Shares Earned
EsopSharesEarned
335000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71753000
CY2023 us-gaap Profit Loss
ProfitLoss
4660000
CY2022 us-gaap Profit Loss
ProfitLoss
5784000
CY2023 us-gaap Depreciation
Depreciation
663000
CY2022 us-gaap Depreciation
Depreciation
675000
CY2023 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-228000
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
492000
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-118000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-614000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-156000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
218000
CY2023 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
172000
CY2022 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
515000
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
-171000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
-275000
CY2023 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
28000
CY2022 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-6000
CY2023 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
388000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
488000
CY2023 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
7554000
CY2022 us-gaap Payments To Purchase Loans Held For Sale
PaymentsToPurchaseLoansHeldForSale
27546000
CY2023 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
7934000
CY2022 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
28016000
CY2023 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
335000
CY2022 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
445000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
327000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
156000
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
758000
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
126000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3053000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-280000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1490000
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-23000
CY2023 us-gaap Increase Decrease In Postretirement Obligations
IncreaseDecreaseInPostretirementObligations
21000
CY2022 us-gaap Increase Decrease In Postretirement Obligations
IncreaseDecreaseInPostretirementObligations
37000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-616000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
369000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2766000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8669000
CY2023 iroq Net Change In Interest Bearing Time Deposits
NetChangeInInterestBearingTimeDeposits
250000
CY2022 iroq Net Change In Interest Bearing Time Deposits
NetChangeInInterestBearingTimeDeposits
750000
CY2023 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
18205000
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
98784000
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7695000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6049000
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
23601000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
33383000
CY2023 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
68373000
CY2022 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
6577000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2250000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
387000
CY2023 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
148000
CY2022 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
253000
CY2023 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1050000
CY2022 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
0
CY2023 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
1065000
CY2022 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
1056000
CY2023 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0
CY2022 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
5000000
CY2023 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0
CY2022 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
454000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57119000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68803000
CY2023 iroq Net Increase Decrease In Demand Deposits Money Market Now And Savings Accounts
NetIncreaseDecreaseInDemandDepositsMoneyMarketNowAndSavingsAccounts
-49826000
CY2022 iroq Net Increase Decrease In Demand Deposits Money Market Now And Savings Accounts
NetIncreaseDecreaseInDemandDepositsMoneyMarketNowAndSavingsAccounts
95880000
CY2023 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
33120000
CY2022 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-11492000
CY2023 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
730000
CY2022 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-425000
CY2023 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
513600000
CY2022 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
0
CY2023 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
509100000
CY2022 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
10000000
CY2023 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0
CY2022 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
3000000
CY2023 iroq Proceeds From Payments For In Securities Sold Under Agreement To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementToRepurchase
1543000
CY2022 iroq Proceeds From Payments For In Securities Sold Under Agreement To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementToRepurchase
2999000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
1269000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
1067000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
732000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
315000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10470000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
73210000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-64823000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13076000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75811000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62735000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10988000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75811000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
8585000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2552000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2096000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1956000
CY2023 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
31000
CY2022 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
120000
CY2023 iroq Number Of Full Service Banking Offices
NumberOfFullServiceBankingOffices
7
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Material estimates that are particularly susceptible to significant change relate to the determination of the allowance for loan losses, fair value measurements of investment securities, loan servicing rights and income taxes. </div>
CY2023 iroq Interest Bearing Deposits Maturity Period
InterestBearingDepositsMaturityPeriod
P3Y
CY2023 iroq Cash And Cash Equivalents Maximum Original Maturity Period
CashAndCashEquivalentsMaximumOriginalMaturityPeriod
P3M
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
350000
CY2023Q2 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
5080000
CY2023 iroq Accrual Of Interest On Loans Due Discontinued Period
AccrualOfInterestOnLoansDueDiscontinuedPeriod
P90D
CY2023Q2 iroq Temporarily Impaired Debt Securities Percentage Of Investment Securities Portfolio
TemporarilyImpairedDebtSecuritiesPercentageOfInvestmentSecuritiesPortfolio
0.97
CY2022Q2 iroq Temporarily Impaired Debt Securities Percentage Of Investment Securities Portfolio
TemporarilyImpairedDebtSecuritiesPercentageOfInvestmentSecuritiesPortfolio
0.95
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
16728000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
506000
CY2023 iroq Income Tax Examination Minimum Likelihood Of Tax Benefits Being Realized Upon Settlement
IncomeTaxExaminationMinimumLikelihoodOfTaxBenefitsBeingRealizedUponSettlement
0.50
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
178090000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
29889000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
194818000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30395000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
169518000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
16877000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
39615000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
7323000
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
209133000
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
231672000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30395000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201299000
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
245052000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
54000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24200000
CY2022Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
220906000
CY2023Q2 iroq Debt Securities Greater Than Stated Percentage Of Equity Securities
DebtSecuritiesGreaterThanStatedPercentageOfEquitySecurities
0.10
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
0
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5956000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5653000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
10996000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
10042000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
11581000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
9878000
CY2023Q2 iroq Debt Securities Available For Sale Amortized Cost
DebtSecuritiesAvailableForSaleAmortizedCost
28533000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
25573000
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
231672000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
201299000
CY2023 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
12000
CY2022 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0
CY2023 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
183000
CY2022 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
275000
CY2022Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24200000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
594324000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
525736000
CY2023Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-272000
CY2022Q2 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-247000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7052000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
587457000
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
518931000
CY2023Q2 iroq Maximum Amount Of One To Four Family Residential Mortgage Loans Can Be Approved By Loan Officer
MaximumAmountOfOneToFourFamilyResidentialMortgageLoansCanBeApprovedByLoanOfficer
100000
CY2023Q2 iroq Maximum Amount Of Other Secured Loans Residential Mortgage Loans Can Be Approved By Loan Officer
MaximumAmountOfOtherSecuredLoansResidentialMortgageLoansCanBeApprovedByLoanOfficer
50000
CY2023Q2 iroq Maximum Amount Of Unsecured Loans Residential Mortgage Loans Can Be Approved By Loan Officer
MaximumAmountOfUnsecuredLoansResidentialMortgageLoansCanBeApprovedByLoanOfficer
10000
CY2023Q2 iroq Maximum Amount Of One To Four Family Residential Mortgage Loans Can Be Approved By Managing Officer
MaximumAmountOfOneToFourFamilyResidentialMortgageLoansCanBeApprovedByManagingOfficer
375000
CY2023Q2 iroq Maximum Amount Of Other Secured Loans Residential Mortgage Loans Can Be Approved By Managing Officer
MaximumAmountOfOtherSecuredLoansResidentialMortgageLoansCanBeApprovedByManagingOfficer
375000
CY2023Q2 iroq Maximum Amount Of Unsecured Loans Residential Mortgage Loans Can Be Approved By Managing Officer
MaximumAmountOfUnsecuredLoansResidentialMortgageLoansCanBeApprovedByManagingOfficer
100000
CY2023Q2 iroq Maximum Aggregate Loan Amount Of One To Four Family Residential Mortgage Loans Commercial Real Estate Loans Multi Family Real Estate Loans And Land Loans Can Be Approved By Loan Committee
MaximumAggregateLoanAmountOfOneToFourFamilyResidentialMortgageLoansCommercialRealEstateLoansMultiFamilyRealEstateLoansAndLandLoansCanBeApprovedByLoanCommittee
2000000
CY2023Q2 iroq Maximum Amount Of Unsecured Loans Residential Mortgage Loans Can Be Approved By Loan Committee
MaximumAmountOfUnsecuredLoansResidentialMortgageLoansCanBeApprovedByLoanCommittee
500000
CY2023 iroq Term Period On Residential Mortgage Loan
TermPeriodOnResidentialMortgageLoan
P15Y
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7052000
CY2023 iroq Impact Of Adopting Asu201613
ImpactOfAdoptingASU201613
47000
CY2023 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
52000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
51000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
39000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7139000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
594324000
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
6599000
CY2022 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
-492000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
67000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
28000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7052000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7052000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
525736000
CY2022Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
1385000
CY2022Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
524351000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
56417000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
212517000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
99138000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
86618000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
29700000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
109934000
CY2023Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
594324000
CY2022Q2 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
525736000
CY2023Q2 iroq Financing Receivable Recorded Investments Past Due
FinancingReceivableRecordedInvestmentsPastDue
981000
CY2023Q2 iroq Financing Receivable Recorded Investments Current
FinancingReceivableRecordedInvestmentsCurrent
593343000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
594324000
CY2022Q2 iroq Financing Receivable Recorded Investments Past Due
FinancingReceivableRecordedInvestmentsPastDue
1791000
CY2022Q2 iroq Financing Receivable Recorded Investments Current
FinancingReceivableRecordedInvestmentsCurrent
523945000
CY2022Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
525736000
CY2022Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
47000
CY2022Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
1385000
CY2022Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
1385000
CY2022Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
0
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
1401000
CY2022 iroq Impaired Financing Receivable Interest Income Loss Accrual Method
ImpairedFinancingReceivableInterestIncomeLossAccrualMethod
19000
CY2022 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
17000
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
117000
CY2022Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1127000
CY2023Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
215000
CY2022Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
998000
CY2022 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
0
CY2023 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
0
CY2023 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2022 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2023Q2 us-gaap Land
Land
2160000
CY2022Q2 us-gaap Land
Land
2028000
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
13298000
CY2022Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
11518000
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4846000
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4663000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20304000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18209000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9212000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8704000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11092000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9505000
CY2023 iroq Unpaid Principal Balances Of Mortgage Loans Serviced For Others
UnpaidPrincipalBalancesOfMortgageLoansServicedForOthers
133228000000
CY2022 iroq Unpaid Principal Balances Of Mortgage Loans Serviced For Others
UnpaidPrincipalBalancesOfMortgageLoansServicedForOthers
141229000000
CY2023Q2 us-gaap Escrow Deposit
EscrowDeposit
1536000000
CY2022Q2 us-gaap Escrow Deposit
EscrowDeposit
691000000
CY2023Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1482000
CY2022Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1463000
CY2022Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1463000
CY2021Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1013000
CY2023 us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
89000
CY2022 us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
287000
CY2023 iroq Servicing Asset At Fair Value Other Change In Fair Value
ServicingAssetAtFairValueOtherChangeInFairValue
-171000
CY2022 iroq Servicing Asset At Fair Value Other Change In Fair Value
ServicingAssetAtFairValueOtherChangeInFairValue
-263000
CY2023 us-gaap Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions
ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions
101000
CY2022 us-gaap Servicing Asset At Fair Value Changes In Fair Value Resulting From Changes In Valuation Inputs Or Changes In Assumptions
ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions
426000
CY2023Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1482000
CY2022Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1463000
CY2023Q2 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
389928000
CY2022Q2 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
435126000
CY2023 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
2942000
CY2022 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
788000
CY2023 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
4391000
CY2022 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1255000
CY2023 iroq Interest Expense Deposit Type Brokered Certificates Of Deposit
InterestExpenseDepositTypeBrokeredCertificatesOfDeposit
664000
CY2022 iroq Interest Expense Deposit Type Brokered Certificates Of Deposit
InterestExpenseDepositTypeBrokeredCertificatesOfDeposit
25000
CY2023 us-gaap Interest Expense Deposits
InterestExpenseDeposits
7997000
CY2022 us-gaap Interest Expense Deposits
InterestExpenseDeposits
2068000
CY2023Q2 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
243743000
CY2023Q2 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
34932000
CY2023Q2 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
3121000
CY2023Q2 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
1447000
CY2023Q2 iroq Time Deposit Maturities Year Five And Thereafter
TimeDepositMaturitiesYearFiveAndThereafter
353000
CY2023Q2 us-gaap Time Deposits
TimeDeposits
283596000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
19500000
CY2022Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
15000000
CY2023Q2 iroq Mortgage Loans Secured For Federal Home Loan Banks Advances
MortgageLoansSecuredForFederalHomeLoanBanksAdvances
350838000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
14000000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
3000000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
2500000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
0
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
0
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
0
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
19500000
CY2023Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
10800000
CY2022Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
9200000
CY2023 iroq Securities Sold Under Repurchase Agreements Maximum Balance
SecuritiesSoldUnderRepurchaseAgreementsMaximumBalance
11050000
CY2022 iroq Securities Sold Under Repurchase Agreements Maximum Balance
SecuritiesSoldUnderRepurchaseAgreementsMaximumBalance
9244000
CY2023 iroq Securities Sold Under Repurchase Agreements Average Balance
SecuritiesSoldUnderRepurchaseAgreementsAverageBalance
10015000
CY2022 iroq Securities Sold Under Repurchase Agreements Average Balance
SecuritiesSoldUnderRepurchaseAgreementsAverageBalance
7277000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1756000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1825000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-156000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
218000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2043000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1315000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1644000
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
22000
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
11000
CY2023 iroq Income Tax Reconciliation Cash Surrender Value Life Insurance
IncomeTaxReconciliationCashSurrenderValueLifeInsurance
81000
CY2022 iroq Income Tax Reconciliation Cash Surrender Value Life Insurance
IncomeTaxReconciliationCashSurrenderValueLifeInsurance
102000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
451000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
570000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-63000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-58000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2043000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
2033000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
2007000
CY2023Q2 iroq Deferred Tax Assets Tax Acl Onoffbalancesheet Credit Exposures
DeferredTaxAssetsTaxAclOnoffbalancesheetCreditExposures
62000
CY2022Q2 iroq Deferred Tax Assets Tax Acl Onoffbalancesheet Credit Exposures
DeferredTaxAssetsTaxAclOnoffbalancesheetCreditExposures
0
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
693000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
714000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
612000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
557000
CY2023Q2 iroq Deferred Tax Assets Tax Deferred Loan Fees
DeferredTaxAssetsTaxDeferredLoanFees
126000
CY2022Q2 iroq Deferred Tax Assets Tax Deferred Loan Fees
DeferredTaxAssetsTaxDeferredLoanFees
115000
CY2023Q2 iroq Deferred Tax Assets Tax Postretirement Health Plan
DeferredTaxAssetsTaxPostretirementHealthPlan
0
CY2022Q2 iroq Deferred Tax Assets Tax Postretirement Health Plan
DeferredTaxAssetsTaxPostretirementHealthPlan
33000
CY2023Q2 iroq Deferred Tax Assets Unrealized Loss On Available For Sale Securities Gross
DeferredTaxAssetsUnrealizedLossOnAvailableForSaleSecuritiesGross
8658000
CY2022Q2 iroq Deferred Tax Assets Unrealized Loss On Available For Sale Securities Gross
DeferredTaxAssetsUnrealizedLossOnAvailableForSaleSecuritiesGross
6883000
CY2023Q2 iroq Deferred Tax Assets Accrued Vacation
DeferredTaxAssetsAccruedVacation
56000
CY2022Q2 iroq Deferred Tax Assets Accrued Vacation
DeferredTaxAssetsAccruedVacation
53000
CY2023Q2 iroq Deferred Tax Assets Tax Deferred Expense Mortgage Partnership Finance Recourse Liability
DeferredTaxAssetsTaxDeferredExpenseMortgagePartnershipFinanceRecourseLiability
36000
CY2022Q2 iroq Deferred Tax Assets Tax Deferred Expense Mortgage Partnership Finance Recourse Liability
DeferredTaxAssetsTaxDeferredExpenseMortgagePartnershipFinanceRecourseLiability
50000
CY2023Q2 iroq Deferred Tax Assets Tax Deferred Revenue Mastercard
DeferredTaxAssetsTaxDeferredRevenueMastercard
12000
CY2022Q2 iroq Deferred Tax Assets Tax Deferred Revenue Mastercard
DeferredTaxAssetsTaxDeferredRevenueMastercard
16000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
54000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
54000
CY2023Q2 iroq Deferred Tax Assets Restricted Stock
DeferredTaxAssetsRestrictedStock
61000
CY2022Q2 iroq Deferred Tax Assets Restricted Stock
DeferredTaxAssetsRestrictedStock
0
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
27000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
18000
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
28000
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
22000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12458000
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10522000
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
698000
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
682000
CY2023Q2 us-gaap Deferred Tax Liabilities Mortgage Servicing Rights
DeferredTaxLiabilitiesMortgageServicingRights
423000
CY2022Q2 us-gaap Deferred Tax Liabilities Mortgage Servicing Rights
DeferredTaxLiabilitiesMortgageServicingRights
417000
CY2023Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
204000
CY2022Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
185000
CY2023Q2 iroq Deferred Tax Liability Restricted Stock
DeferredTaxLiabilityRestrictedStock
0
CY2022Q2 iroq Deferred Tax Liability Restricted Stock
DeferredTaxLiabilityRestrictedStock
32000
CY2023Q2 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
69000
CY2022Q2 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
40000
CY2023Q2 iroq Deferred Tax Liability Postretirement Health Plan
DeferredTaxLiabilityPostretirementHealthPlan
27000
CY2022Q2 iroq Deferred Tax Liability Postretirement Health Plan
DeferredTaxLiabilityPostretirementHealthPlan
0
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1421000
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1356000
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11037000
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
9166000
CY2023Q2 iroq Retained Earnings Excluding Deferred Federal Income Tax Liability
RetainedEarningsExcludingDeferredFederalIncomeTaxLiability
2217000
CY2023Q2 iroq Amount Deferred Income Tax Liabilities Expected To Reverse Into Taxable Income
AmountDeferredIncomeTaxLiabilitiesExpectedToReverseIntoTaxableIncome
466000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17346000
CY2023 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-4574000
CY2023 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-122000
CY2023 iroq Other Comprehensive Income Loss Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionsAttributableToParent
150000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21648000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1933000
CY2022 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-19821000
CY2022 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-197000
CY2022 iroq Other Comprehensive Income Loss Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionsAttributableToParent
345000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17346000
CY2023Q2 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.025
CY2023Q2 iroq Maximum Asset Value Required To Be Maintained Leverage Ratio
MaximumAssetValueRequiredToBeMaintainedLeverageRatio
10000000000
CY2022Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2620000
CY2023Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
CY2022Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
CY2023Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-2431000
CY2022Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-2620000
CY2023Q2 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
2431000
CY2022Q2 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
2620000
CY2023 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0402
CY2022 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0265
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
162986
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
153000
CY2022Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2620000
CY2021Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
3065000
CY2023 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
43000
CY2022 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
48000
CY2023 iroq Defined Benefit Plan Interest Costs
DefinedBenefitPlanInterestCosts
102000
CY2022 iroq Defined Benefit Plan Interest Costs
DefinedBenefitPlanInterestCosts
79000
CY2023 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
210000
CY2022 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
449000
CY2023 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
124000
CY2022 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
123000
CY2023Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2431000
CY2022Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2620000
CY2023Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2431000
CY2023Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
2431000
CY2022Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent
2620000
CY2023 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
43000
CY2022 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
48000
CY2023 iroq Defined Benefit Plan Interest Costs
DefinedBenefitPlanInterestCosts
102000
CY2022 iroq Defined Benefit Plan Interest Costs
DefinedBenefitPlanInterestCosts
79000
CY2023 iroq Defined Benefit Plan Amortisation Of Gains Losses
DefinedBenefitPlanAmortisationOfGainsLosses
0
CY2022 iroq Defined Benefit Plan Amortisation Of Gains Losses
DefinedBenefitPlanAmortisationOfGainsLosses
-27000
CY2023 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
145000
CY2022 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
154000
CY2023Q2 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
153000
CY2022Q2 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
-57000
CY2023 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
124000
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
124000
CY2023 iroq Benefits Paid
BenefitsPaid
124000
CY2022 iroq Benefits Paid
BenefitsPaid
123000
CY2023 iroq Benefit Costs
BenefitCosts
145000
CY2022 iroq Benefit Costs
BenefitCosts
154000
CY2023Q2 us-gaap Defined Benefit Plan Expected Amortization Of Gain Loss Next Fiscal Year
DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear
0
CY2023Q2 us-gaap Defined Benefit Plan Expected Amortization Of Prior Service Cost Credit Next Fiscal Year
DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear
0
CY2023Q2 us-gaap Defined Benefit Plan Expected Amortization Of Transition Asset Obligation Next Fiscal Year
DefinedBenefitPlanExpectedAmortizationOfTransitionAssetObligationNextFiscalYear
0
CY2023Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0476
CY2022Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0402
CY2023 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Service And Interest Cost Components
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents
4000
CY2023 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Service And Interest Cost Components1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1
4000
CY2023 us-gaap Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation
DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation
27000
CY2023 us-gaap Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1
DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1
25000
CY2023Q2 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate1
DefinedBenefitPlanUltimateHealthCareCostTrendRate1
0.09
CY2024Q2 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate1
DefinedBenefitPlanUltimateHealthCareCostTrendRate1
0.085
CY2025Q2 us-gaap Defined Benefit Plan Ultimate Health Care Cost Trend Rate1
DefinedBenefitPlanUltimateHealthCareCostTrendRate1
0.085
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
138415000
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
157528000
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
186489000
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
195695000
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
206541000
CY2023Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
949153000
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.05
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
91000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
90000
CY2023 iroq Defined Benefit Plan Retirement Age
DefinedBenefitPlanRetirementAge
P72Y
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
2100000
CY2022Q2 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
2000000
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
160772
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
19245
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares
EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares
19245
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
153960
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Suspense Shares
EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares
173205
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
336191
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
353222
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
2223000
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
3291000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
134143
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.63
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.63
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
90143
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.63
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
90143
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.63
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y4M24D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2023Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1250000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
587457000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3127000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
2781000
CY2023Q2 us-gaap Deposits
Deposits
735314000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4660000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
5784000
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3276890
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
3252707
CY2023 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
163583
CY2022 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
182828
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3113307
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3069879
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
81722
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66212
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3195029
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3136091
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.5
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.88
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.84
CY2023Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1482000
CY2022Q2 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1463000
CY2023Q2 iroq Mortgage Servicing Rights Fair Value Disclosure
MortgageServicingRightsFairValueDisclosure
1482000
CY2023 iroq Impaired Loans Gain Losses Recognized On Assets Fair Value Disclosure
ImpairedLoansGainLossesRecognizedOnAssetsFairValueDisclosure
2361000
CY2022Q2 iroq Mortgage Servicing Rights Fair Value Disclosure
MortgageServicingRightsFairValueDisclosure
1463000
CY2022 iroq Impaired Loans Gain Losses Recognized On Assets Fair Value Disclosure
ImpairedLoansGainLossesRecognizedOnAssetsFairValueDisclosure
2662000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10988000
CY2023Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
10787000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
19500000
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1233000
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1666000
CY2023Q2 iroq Commitments To Originate Loans
CommitmentsToOriginateLoans
0
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75811000
CY2022Q2 iroq Interest Bearing Time Deposits In Banks
InterestBearingTimeDepositsInBanks
1500000
CY2022Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
518931000
CY2022Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3142000
CY2022Q2 us-gaap Interest Receivable
InterestReceivable
2023000
CY2022Q2 us-gaap Deposits
Deposits
752020000
CY2022Q2 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
9244000
CY2022Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
15000000
CY2022Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
503000
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
176000
CY2022Q2 iroq Commitments To Originate Loans
CommitmentsToOriginateLoans
0
CY2023Q2 iroq Commitments Outstanding Amount
CommitmentsOutstandingAmount
5081000
CY2022Q2 iroq Commitments Outstanding Amount
CommitmentsOutstandingAmount
28024000
CY2023 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
3454200
CY2022 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
15704000
CY2023Q2 iroq Weighted Average Interest Rates For Fixedrate Loan Commitments
WeightedAverageInterestRatesForFixedrateLoanCommitments
0.0748
CY2022Q2 iroq Weighted Average Interest Rates For Fixedrate Loan Commitments
WeightedAverageInterestRatesForFixedrateLoanCommitments
0.0436
CY2022Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
496000000
CY2023 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
280000
CY2023Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
216000

Files In Submission

Name View Source Status
0001193125-23-234137-index-headers.html Edgar Link pending
0001193125-23-234137-index.html Edgar Link pending
0001193125-23-234137.txt Edgar Link pending
0001193125-23-234137-xbrl.zip Edgar Link pending
d547517d10k.htm Edgar Link pending
d547517dex230.htm Edgar Link pending
d547517dex311.htm Edgar Link pending
d547517dex312.htm Edgar Link pending
d547517dex320.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iroq-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
iroq-20230630_cal.xml Edgar Link unprocessable
iroq-20230630_def.xml Edgar Link unprocessable
iroq-20230630_lab.xml Edgar Link unprocessable
iroq-20230630_pre.xml Edgar Link unprocessable
d547517d10k_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending